Clozapine use and prevalence in Australia 2016-2020

Aust N Z J Psychiatry. 2022 Mar;56(3):305-306. doi: 10.1177/00048674211025693. Epub 2021 Jul 5.

Authors

Samantha A Hollingworth¹, Adrian Oliver¹, Karl Winckel^{1

2}, Dan Siskind^{3

4}

Affiliations

¹ School of Pharmacy, The University of Queensland, Woolloongabba, QLD, Australia.
² Pharmacy Department, Princess Alexandra Hospital, Woolloongabba, QLD, Australia.
³ School of Clinical Medicine, The University of Queensland, Woolloongabba, QLD, Australia.
⁴ Metro South Addiction and Mental Health Service, Woolloongabba, QLD, Australia.

PMID: 34219480
DOI: 10.1177/00048674211025693

No abstract available

Publication types

Letter

MeSH terms

Antipsychotic Agents* / adverse effects
Australia / epidemiology
Clozapine* / adverse effects
Humans
Prevalence

Substances

Antipsychotic Agents
Clozapine